New functionally-enhanced soy proteins as food ingredients with anti-viral activity
- 116 Downloads
Respiratory viruses are a major public health problem because of their prevalence and high morbidity rate leading to considerable social and economic implications. Cranberry has therapeutic potential attributed to a comprehensive list of phytochemicals including anthocyanins, flavonols, and unique A-type proanthocyanidins. Soy flavonoids, including isoflavones, have demonstrated anti-viral effects in vitro and in vivo. Recently, it was demonstrated that edible proteins can efficiently sorb and concentrate cranberry polyphenols, including anthocyanins and proanthocyanins, providing greatly stabilized matrices suitable for food products. The combination of cranberry and soy phytoactives may be an effective dietary anti-viral resource. Anti-viral properties of both cranberry juice-enriched and cranberry pomace polyphenol-enriched soy protein isolate (CB-SPI and CBP-SPI) were tested against influenza viruses (H7N1, H5N3, H3N2), Newcastle disease virus and Sendai virus in vitro and in ovo. In our experiments, preincubation with CB-SPI or CBP-SPI resulted in inhibition of virus adsorption to chicken red blood cells and reduction in virus nucleic acid content up to 16-fold, however, CB-SPI and CBP-SPI did not affect hemagglutination. Additionally, CB-SPI and CBP-SPI inhibited viral replication and infectivity more effectively than the commercially available anti-viral drug Amizon. Results suggest CB-SPI and CBP-SPI may have preventative and therapeutic potential against viral infections that cause diseases of the respiratory and gastro-intestinal tract.
KeywordsCranberry Polyphenols Flavonoids Anti-viral
This work was supported by Grants 0113PK00473 and 0114PK00303 from the Ministry of Education and Science of the Republic of Kazakhstan, Grant PSC-CUNY 66638-00 44 and an SBIR Phase 1 grant from the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Grant 1R43DK092104-01A1. Diana M. Cheng was supported by NIH training grant T32: 5T32AT004094-04.
- 15.Grace M, Guzman I, Roopchand ED, Moskal K, Cheng MD, Pogrebnyak N, Raskin I, Howell A, Lila MA. Stable binding of alternative protein-enriched food matrices with concentrated cranberry bioflavonoids for functional food applications. J Agric Food Chem. 2013;61:6856–64.PubMedCentralCrossRefPubMedGoogle Scholar
- 21.Morodomi Y, Inoue M, Hasegawa M, Okamoto T, Maehara Y, Yonemitsu Y. Sendai virus-based oncolytic gene therapy. In: Wei M, Good D, editors. Novel gene therapy approaches. Rijeka: InTech Publisher; 2013. p. 183–94.Google Scholar
- 30.Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Epidemiol. 1938;27:493–7.Google Scholar
- 36.Singleton VL, Orthofer R, Lamuela-Raventós RM. Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent. In: Lester P, editor. Methods in enzymology. New York: Academic Press; 1999. p. 152–78.Google Scholar